You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

byl719

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • BYL719
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • BYl719
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)

Completed
  • Metastatic or Locally-advanced Unresectable Breast Cancer
  • BYL719
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022

Head and Neck Squamous Cell Cancer Trial in United States (Cetuximab, BYL719, IMRT (Intensity-Modulated Radiation Therapy))

Completed
  • Head and Neck Squamous Cell Cancer
  • Basking Ridge, New Jersey
  • +5 more
Oct 22, 2021

Pancreatic Cancer Trial in Tampa (BYL719, Gemcitabine, (nab)-paclitaxel)

Completed
  • Pancreatic Cancer
  • BYL719
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 6, 2021

Breast Cancer Trial in United States (BYL719, LJM716, TRASTUZUMAB)

Completed
  • Breast Cancer
  • BYL719
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Jul 8, 2021

Squamous Cell Carcinoma of Head and Neck, Locoregionally Advanced Trial in Toronto (BYL719, Cisplatin, Intensity modulated

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • Locoregionally Advanced
  • BYL719
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 16, 2021

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • San Diego, California
  • +23 more
Feb 17, 2022

Rectal Cancer Trial in Providence (BYL719, Capecitabine, Radiation)

Terminated
Has Results
  • Rectal Cancer
  • BYL719
  • +2 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Mar 11, 2021

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • BYL719
  • +4 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022

Advanced Solid Tumor Trial in Nagoya, Chuo-ku, Koto-ku (BYL719)

Completed
  • Advanced Solid Tumor
  • BYL719
  • Nagoya, Aichi, Japan
  • +3 more
Dec 6, 2020

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma Trial in Guangzhou (BYL719, INC280, LDK378)

Completed
Has Results
  • Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma
  • BYL719
  • +3 more
  • Guangzhou, Guangdong, China
    Novartis Investigative Site
Nov 20, 2020

Relapsed and Refractory Multiple Myeloma Trial in Worldwide (LGH447, BYL719)

Completed
  • Relapsed and Refractory Multiple Myeloma
  • Houston, Texas
  • +7 more
Dec 16, 2020

Tumors, Breast Tumors, Head and Neck Tumors Trial in Worldwide (BYL719, Paclitaxel)

Completed
  • Neoplasms, Breast Neoplasms, Head and Neck Neoplasms
  • Fayetteville, Arkansas
  • +4 more
Dec 4, 2020

Breast Cancer Trial in Worldwide (LEE011, BYL719, fulvestrant)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +10 more
Dec 16, 2020

Stomach Tumors Esophageal Tumors Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein Trial in Worldwide

Completed
  • Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
  • Boston, Massachusetts
  • +8 more
Dec 6, 2020

Esophageal Squamous Cell Carcinoma Trial in Worldwide (LJM716, BYL719, Paclitaxel)

Completed
  • Esophageal Squamous Cell Carcinoma
  • Chicago, Illinois
  • +12 more
Dec 16, 2020

Metastatic Breast Cancer Trial in Chapel Hill, Durham (BMK120, Capecitabine, BYL719)

Completed
  • Metastatic Breast Cancer
  • Chapel Hill, North Carolina
  • +1 more
Aug 24, 2020

Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer Trial in Worldwide

Completed
  • Advanced Solid Tumors With an Alteration of the PIK3CA Gene
  • Estrogen Receptor Positive Breast Cancer
  • San Francisco, California
  • +10 more
Sep 21, 2020

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (BGJ398, BYL719)

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Tampa, Florida
  • +21 more
Dec 6, 2020

Colorectal Cancer Trial in Worldwide (LGX818, Cetuximab, BYL719)

Completed
Has Results
  • Colorectal Cancer
  • Los Angeles, California
  • +51 more
May 26, 2021

Uveal Melanoma Trial in Miami, New York (AEB071, BYL719)

Unknown status
  • Uveal Melanoma
  • Miami, Florida
  • +2 more
Jun 29, 2018

PIK3CA Mutated Advanced Solid Tumors, PIK3CA Amplified Advanced Solid Tumors Trial in Worldwide (BYL719, AMG 479)

Terminated
Has Results
  • PIK3CA Mutated Advanced Solid Tumors
  • PIK3CA Amplified Advanced Solid Tumors
  • BYL719
  • AMG 479
  • Los Angeles, California
  • +9 more
Aug 15, 2018

Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Trial in Seoul (BYL719)

Unknown status
  • Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
  • BYL719
  • Seoul, Korea, Republic of
    Yonsei Cancer Center at Yonsei University Medical Center
Jul 15, 2018

Carcinoma, Squamous, Squamous Cell Carcinoma, Oropharyngeal Tumors Trial (cisplatin, Cetuximab, BYL719)

Withdrawn
  • Carcinoma, Squamous
  • +3 more
  • (no location specified)
Nov 8, 2017